← Leaderboards
Paul B Watkins
University Of Michigan At Ann Arbor
$20,798,906
Attributed
$34,929,371
Total exposure
34
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,990,433 · 33
FDA$11,938,938 · 1
By mechanism
U01$18,866,711 · 2
T32$7,764,392 · 1
R37$3,799,194 · 1
KL2$2,256,133 · 1
U13$1,247,903 · 1
M01$827,193 · 27
Top collaborators
- Kim L Brouwer16 shared
- Susan Halabi10 shared
- Robert John Mentz10 shared
- Ehsan Samei10 shared
- Daniel K Benjamin7 shared
- Michael Cohen-Wolkowiez6 shared
- Daniel Gonzalez3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Rodney A Hayward$1,667,848
- Karen Eileen Peterson$10,423,408
- Peter Xuekun Song$4,205,299
- Ruma V Banerjee$24,139,300
- Robert Pickett Dickson$8,802,133
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchResearch PersonnelResourcesFundingLiverPharmaceutical PreparationsInstitutionEnrollmentUniversitiesNorth CarolinaCollaborationsLeadGeneticHuman SubjectAncillary StudyEtiologyWeb SiteDesignGrantLeadershipUnited States National Institutes Of HealthScientistTraining ProgramsPost-Doctoral Training
Grant awards (102)
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$799,378
T32 · FY2025 · GM
Research Triangle Center of Excellence in Regulatory Science and Innovation$525,000
U01 · FY2025 · FD · contact PI
University of North Carolina Clinical Center for DILIN$377,032
U01 · FY2025 · DK · contact PI
Research Triangle Center of Excellence in Regulatory Science and Innovation$2,033,969
U01 · FY2024 · FD · contact PI
Research Triangle Center of Excellence in Regulatory Science and Innovation$949,206
U01 · FY2024 · FD · contact PI
Research Triangle Center of Excellence in Regulatory Science and Innovation$867,730
U01 · FY2024 · FD · contact PI
Research Triangle Center of Excellence in Regulatory Science and Innovation$750,000
U01 · FY2024 · FD · contact PI
Research Triangle Center of Excellence in Regulatory Science and Innovation$668,333
U01 · FY2024 · FD · contact PI
Research Triangle Center of Excellence in Regulatory Science and Innovation$454,318
U01 · FY2024 · FD · contact PI
Research Triangle Center of Excellence in Regulatory Science and Innovation$450,533
U01 · FY2024 · FD · contact PI
Research Triangle Center of Excellence in Regulatory Science and Innovation$376,307
U01 · FY2024 · FD · contact PI
University of North Carolina Clinical Center for DILIN$368,806
U01 · FY2024 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$1
T32 · FY2024 · GM
Research Triangle Center of Excellence in Regulatory Science and Innovation$4,863,542
U01 · FY2023 · FD · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$744,336
T32 · FY2023 · GM
University of North Carolina Clinical Center for DILIN$398,587
U01 · FY2023 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$710,612
T32 · FY2022 · GM
University of North Carolina Clinical Center for DILIN$349,335
U01 · FY2022 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$706,465
T32 · FY2021 · GM
University of North Carolina Clinical Center for DILIN$349,335
U01 · FY2021 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$550,453
T32 · FY2020 · GM
University of North Carolina Clinical Center for DILIN$349,338
U01 · FY2020 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation Supplement$86,400
T32 · FY2020 · GM
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$737,877
T32 · FY2019 · GM
University of North Carolina Clinical Center for DILIN$349,332
U01 · FY2019 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$696,677
T32 · FY2018 · GM
University of North Carolina Clinical Center for DILIN$302,420
U01 · FY2018 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$624,326
T32 · FY2017 · GM
University of North Carolina Clinical Center for DILIN$386,930
U01 · FY2017 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$446,978
T32 · FY2016 · GM
University of North Carolina Clinical Center for DILIN$307,359
U01 · FY2016 · DK · contact PI
University of North Carolina Clinical Center for DILIN$363,110
U01 · FY2015 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$272,007
T32 · FY2015 · GM
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$399,970
T32 · FY2014 · GM
University of North Carolina Clinical Center for DILIN$258,218
U01 · FY2014 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$389,699
T32 · FY2013 · GM
University of North Carolina Clinical Center for DILIN$271,218
U01 · FY2013 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$382,402
T32 · FY2012 · GM
Drug-Induced Liver Injury Network (DILIN)$295,438
U01 · FY2012 · DK · contact PI
Drug-Induced Liver Injury Network (DILIN)$315,971
U01 · FY2011 · DK · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$216,811
T32 · FY2011 · GM
Drug-Induced Liver Injury Network (DILIN)$163,249
U01 · FY2010 · DK · contact PI
Drug-Induced Liver Injury Network (DILIN)$201,082
U01 · FY2009 · DK · contact PI
UNC Clinical Translation Science Award-K12 Scholars Program (KL2)$2,256,133
KL2 · FY2008 · RR · contact PI
Drug-Induced Liver Injury Network (DILIN)$259,405
U01 · FY2008 · DK · contact PI
UNC Clinical Translation Science Award-T32 Program (TL1)$167,845
TL1 · FY2008 · RR · contact PI
TOXICOGENOMICS OF ACETAMINOPHEN HEPATOTOXICITY- RECHALLENGE PROTOCOL$54,329
M01 · FY2008 · RR · contact PI
TOXICOGENOMICS OF ACETAMINOPHEN HEPATOTOXICITY$31,526
M01 · FY2008 · RR · contact PI
ENVIRONMENTAL POLYMORPHISMS REGISTRY$11,937
M01 · FY2008 · RR · contact PI
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY$3,061
M01 · FY2008 · RR · contact PI
EFFECT OF ACETAMINOPHEN (TYLENOL) ON HUMAN LYMPHOCYTES$2,908
M01 · FY2008 · RR · contact PI
ACETAMINOPHEN (TYLENOL?) INDUCED HUMAN LYMPHOCYTE TOXICITY$76
M01 · FY2008 · RR · contact PI
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$565,155
R37 · FY2007 · GM · contact PI
GENE EXPRESSION AND ACETAMINOPHEN$299,377
M01 · FY2007 · RR · contact PI
Hepatoxicity Clincal Research Network$201,480
U01 · FY2007 · DK · contact PI
ENVIRONMENTAL POLYMORPHISMS REGISTRY$142,186
M01 · FY2007 · RR · contact PI
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY$7,691
M01 · FY2007 · RR · contact PI
EFFECT OF ACETAMINOPHEN (TYLENOL) ON HUMAN LYMPHOCYTES$5,065
M01 · FY2007 · RR · contact PI
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$510,320
R37 · FY2006 · GM · contact PI
Hepatoxicity Clincal Research Network$201,480
U01 · FY2006 · DK · contact PI
General Clinical Research Centers Annual Meeting$77,598
U13 · FY2006 · RR · contact PI
ENVIRONMENTAL POLYMORPHISMS REGISTRY$72,851
M01 · FY2006 · RR · contact PI
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$56,825
R37 · FY2006 · GM · contact PI
TOXICOGENOMICS OF ACETAMINOPHEN TOXICITY$18,585
M01 · FY2006 · RR · contact PI
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY$9,911
M01 · FY2006 · RR · contact PI
ROLE OF CYTOCHROME P450 3A5 GENOTYPE UPON FLUCONAZOLE/MIDAZOLAM$4,956
M01 · FY2006 · RR · contact PI
DRUG INDUCED LIVER INJURY NETWORK-IDIOSYNCRATIC LIVER INJURY$248
M01 · FY2006 · RR · contact PI
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$507,465
R37 · FY2005 · GM
General Clinical Research Centers Annual Meeting$292,629
U13 · FY2005 · RR
Hepatoxicity Clincal Research Network$201,480
U01 · FY2005 · DK
TOXICOGENOMICS OF ACETAMINOPHEN TOXICITY$49,008
M01 · FY2005 · RR
General Clinical Research Centers Annual Meeting$41,000
U13 · FY2005 · RR
ROLE OF CYTOCHROME P450 3A5 GENOTYPE UPON FLUCONAZOLE/MIDAZOLAM$4,712
M01 · FY2005 · RR
General Clinical Research Centers Annual Meeting$960
U13 · FY2005 · RR
GENETIC DATABASE FOR GENETIC POLYMORPHISMS IMPLICATED IN DRUG METABOLISM$629
M01 · FY2005 · RR
DRUG INDUCED LIVER INJURY NETWORK-IDIOSYNCRATIC LIVER INJURY$629
M01 · FY2005 · RR
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY$314
M01 · FY2005 · RR
FC-FREE GRAPEFRUIT JUICE ON THE ORAL CLEARANCE OF FELODIPINE AND CYCLOSPORIN$314
M01 · FY2005 · RR
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$492,770
R37 · FY2004 · GM
Hepatoxicity Clincal Research Network$328,584
U01 · FY2004 · DK
General Clinical Research Centers Annual Meeting$284,105
U13 · FY2004 · RR
FC-Free Grapefruit Juice on the Oral Clearance of Felodipine and Cyclosporin$99,340
M01 · FY2004 · RR
General Clinical Research Centers Annual Meeting$53,081
U13 · FY2004 · RR
Cytochrome P450 3A5 Genotype with Measures of Blood Pressure and Cardiovascular$3,396
M01 · FY2004 · RR
Role of Cytochrome P450 3A5 Genotype upon Fluconazole/Midazolam$3,114
M01 · FY2004 · RR
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$478,503
R37 · FY2003 · GM
Hepatoxicity Clincal Research Network$328,584
U01 · FY2003 · DK
General Clinical Research Centers Annual Meeting$252,268
U13 · FY2003 · RR
General Clinical Research Centers Annual Meeting$30,000
U13 · FY2003 · RR
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$405,275
R37 · FY2002 · GM
General Clinical Research Centers Annual Meeting$216,262
U13 · FY2002 · RR
13C ERYTHROMYCIN BREATH TEST TO DETERMINE DRUG DOSAGES$0
M01 · FY2002 · RR
GENETIC FACTORS AND AUTOANTIBODIES IN DRUG INDUCED DISEASE$0
M01 · FY2002 · RR
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$395,992
R37 · FY2001 · GM
FURANOCOUMARINS AND DRUGS EFFECT ON CYP3A4$386,889
R37 · FY2000 · GM
GRAPEFRUIT JUICE COMPONENT RESPONSIBLE FOR ENHANCING FELODIPINE BIOAVAILABILITY$206
M01 · FY2000 · RR
CYCLOSPORIN A BIOAVAILABILITY FROM HEPATIC &ENTERIC P450 3A4 CATALYTIC ACTIVITY$206
M01 · FY2000 · RR
EFFECT OF GRAPEFRUIT JUICE &SEVILLE ORANGE JUICE ON FELODIPINE DISPOSITION$206
M01 · FY2000 · RR
P450 ACTIVITY AND INTESTINAL GENE EXPRESSION PREDICTS TACROLIMUS BIOAVAILABILITY$206
M01 · FY2000 · RR
DIET &MEDICATIONS ON EXPRESSION OF CYP3A4 &CYP3A5 IN INTESTINAL MUCOSA$206
M01 · FY2000 · RR
GENETIC FACTORS AND AUTOANTIBODIES IN DRUG INDUCED DISEASE$0
M01 · FY2000 · RR
13C ERYTHROMYCIN BREATH TEST TO DETERMINE DRUG DOSAGES$0
M01 · FY2000 · RR